Find transparent GLP-1 pricing from licensed providers in your state. Semaglutide, tirzepatide, Ozempic, Wegovy, Mounjaro and Zepbound — delivered to your door after a free online doctor consultation.
Compare GLP-1 pricing across all major medications. Find compounded semaglutide — the cheapest GLP-1 option — or insurance-covered brand-name alternatives starting at $25/month copay.
Get Lowest Price — Free VisitThree simple steps to get GLP-1 medication delivered to your door
Enter your city or ZIP code. We match you with GLP-1 providers licensed in your state.
A licensed physician reviews your assessment and prescribes the right GLP-1 within 24 hours.
Your GLP-1 medication arrives within 2-3 business days with free discreet shipping and all supplies.
All GLP-1 medications ranked from cheapest to most expensive
Most affordable GLP-1 option. Same active ingredient as Ozempic and Wegovy, prepared by licensed 503A/503B pharmacies. No insurance required — transparent monthly pricing.
More affordable tirzepatide. Same molecule as Mounjaro and Zepbound ($1,000+/month brand-name) with the greatest weight loss potential, at a fraction of brand-name pricing.
FDA-approved semaglutide. Insurance may cover for diabetes (Ozempic) or weight loss (Wegovy). With Novo Nordisk savings card, cost can drop to $25-$50/month.
FDA-approved tirzepatide. Lilly savings card can reduce cost by up to $573/month for commercially insured patients. Best results when combined with lifestyle changes.
Clinical outcomes across STEP-1 (semaglutide) and SURMOUNT-1 (tirzepatide) trials
Affordable payment options for every budget
Find out instantly if your insurance covers Ozempic, Wegovy, Mounjaro, or Zepbound. Coverage varies widely, and our team helps verify benefits at no cost to you.
GLP-1 medications are HSA/FSA eligible. Pay with pre-tax dollars and effectively save 20-35% depending on your tax bracket — one of the best ways to reduce costs.
Compounded GLP-1 medications are the most affordable option for cash-pay patients. Free online doctor consultation for semaglutide, compounded versions contain the same active ingredients as brand-name.
Novo Nordisk (Wegovy, Ozempic) and Eli Lilly (Mounjaro, Zepbound) offer savings cards that can reduce brand-name costs dramatically for commercially insured patients.
Low-income patients may qualify for free or reduced-cost GLP-1 medication through Novo Nordisk's Patient Assistance Program or Lilly Cares. Eligibility is income-based.
Select your state to compare GLP-1 prices serving your area
The cost of GLP-1 medications in 2026 varies widely by medication, ranging from affordable compounded alternatives to $1,350/month (brand-name Wegovy without insurance). With insurance coverage, out-of-pocket costs can drop to $25-$50/month for eligible patients. Manufacturer savings cards from Novo Nordisk and Eli Lilly offer additional discounts. HSA/FSA payment saves an additional 20-35% via pre-tax dollars. Your exact cost on a compounded GLP-1 program is determined during your free online consultation with a licensed physician.
Here is the complete 2026 GLP-1 pricing landscape: Compounded Semaglutide (affordable cash-pay cheapest option, no insurance needed). Compounded Tirzepatide (most effective low-cost option). Ozempic: $900-$1,000/month retail (diabetic indication, $25-$50/mo with insurance + savings card). Wegovy: $1,349/month retail (weight loss, $25/mo with coverage + card). Mounjaro: $1,000-$1,200/month retail (diabetic, $25/mo with card). Zepbound: $1,060/month retail ($487 with Lilly savings card). Exact compounded pricing is determined during your free online consultation.
Ozempic retail cost: $900-$1,000/month in most U.S. pharmacies in 2026. Ozempic is FDA-approved for type 2 diabetes and covered by most commercial insurance plans and Medicare Part D for diabetic patients. With insurance + Novo Nordisk savings card, commercially insured diabetic patients typically pay $25-$50/month. Ozempic is not FDA-approved for weight loss — patients using it off-label for weight loss typically pay retail unless they have a diabetes diagnosis.
Wegovy retail cost: $1,349/month in 2026 without insurance — one of the most expensive GLP-1 medications. Wegovy is FDA-approved specifically for chronic weight management, making it more frequently covered by insurance plans for weight loss indications than Ozempic. With commercial insurance + Novo Nordisk savings card, Wegovy costs as little as $25/month. Medicare does not currently cover Wegovy for weight loss.
Mounjaro retail cost: $1,000-$1,200/month without insurance. FDA-approved for type 2 diabetes and covered by most commercial insurance plans and Medicare Part D for diabetic patients. Eli Lilly\'s Mounjaro savings card reduces costs to $25/month for commercially insured patients. Mounjaro contains tirzepatide, the most effective GLP-1 medication for weight loss with up to 22.5% average weight loss in clinical trials.
Zepbound retail cost: $1,060/month for all dose strengths in 2026. FDA-approved specifically for chronic weight management. Eli Lilly\'s savings card can reduce Zepbound costs by up to $573/month for commercially insured patients, bringing the effective cost to approximately $487/month. Medicare does not currently cover Zepbound for weight loss. Zepbound contains the same tirzepatide as Mounjaro but with a different indication.
The cheapest GLP-1 option for cash-pay patients is compounded semaglutide, followed by compounded tirzepatide. Compounded GLP-1 medications are prepared by licensed 503A/503B pharmacies regulated by state boards and the FDA. They contain the same active pharmaceutical ingredients as Ozempic, Wegovy, Mounjaro, and Zepbound but cost 75-85% less. Compounded pricing typically bundles doctor consultation, prescription, and shipping into one flat monthly rate.
Several strategies can dramatically reduce your GLP-1 cost: (1) Check insurance coverage — many plans cover Ozempic, Mounjaro, Wegovy, and Zepbound with prior authorization. (2) Apply for manufacturer savings cards — Novo Nordisk and Eli Lilly offer substantial discounts for commercially insured patients. (3) Use HSA/FSA pre-tax dollars — saves 20-35% depending on tax bracket. (4) Consider compounded GLP-1 — typically cheaper than even insurance copays on brand-name medications. (5) Apply for patient assistance programs if low-income.
Insurance coverage varies significantly by state and plan. Many commercial plans cover Ozempic and Mounjaro for type 2 diabetes with prior authorization. Wegovy and Zepbound (for weight loss specifically) are covered by an increasing number of employer plans. Medicare Part D generally covers Ozempic and Mounjaro for diabetes but not Wegovy or Zepbound for weight loss. Your local telehealth provider can verify your benefits and help submit prior authorization on your behalf.
Most adults qualify for GLP-1 weight loss treatment with a BMI of 30 or higher (obese), or a BMI of 27 or higher (overweight) with at least one weight-related condition such as hypertension, type 2 diabetes, high cholesterol, or sleep apnea. FDA-guided eligibility is standardized, and a free 5-minute online assessment confirms whether GLP-1 treatment is right for you.
Common side effects include nausea, diarrhea, decreased appetite, vomiting, and mild constipation — most of which are mild and resolve within the first 4 weeks as your body adjusts. Serious but rare risks include pancreatitis, gallbladder issues, and thyroid concerns. Your provider will start you on a low dose and titrate up gradually. Regular virtual check-ins ensure your safety and adjust dosing as needed. GLP-1 medications have been studied extensively for over a decade and have a well-established safety profile when used under medical supervision.
Compare all GLP-1 costs and find your best option — from affordable compounded GLP-1 to insurance-covered brand-name with $25 copays. Free 5-minute online assessment.
See My GLP-1 Price — Free Visit